The global direct-to-consumer genetic testing market size was US$ 1,338.6 million in 2021. The global direct-to-consumer genetic testing market size is forecast to reach US$ 5,573.5 million by 2030, growing at a compound annual growth rate (CAGR) of 17.6% during the forecast period from 2022 to 2030.

Direct-to-consumer (DTC) genetic testing is a marketing strategy that uses television, print media, and the Internet to advertise genetic tests to customers. Furthermore, the tests can be purchased online or in stores, and this marketing takes place without the involvement of a health care physician. Customers send their DNA samples directly to the company, and the results are available in the form of electronic reports on their website. Direct-to-consumer genetic testing provides convenience for people who live in remote areas because they don't have to deal with insurance companies and healthcare providers.

?Factors Influencing Market Growth

Global market drivers include the rising acceptance of DTC genetic testing for its abilities for early disease diagnosis and recognition of genetic mutation preceding its manifestation.
The higher prices of (DTC) genetic testing and flaws in the testing kits are rising the risk associated with false interpretations and may slow down the market growth.
The growing advancement in technology due to the rising R&D activities has allowed researchers and healthcare specialists to interpret the information in human genetic material and derive useful understandings to aid in treating various diseases. It has resulted in the development of many direct-to-consumer genetic tests. Thus, this factor is forecast to create lucrative opportunities for the global market.
Impact Analysis of COVID-19

COVID-19 pandemic positively impacted the direct-to-consumer genetic testing market. During the COVID-19 pandemic, technological advancements have created new business opportunities in direct-to-consumer genetic testing. The rapid development of direct-to-consumer genetic testing was due to the growing number of chronic diseases and the introduction of personalized testing kits for niche therapeutic areas. Such transformation and evolution in services have boosted the demand for such kits. Also, the availability of these kits on online platforms has boosted the global market growth.

Regional Insights

North America accounted for the largest market share in 2021. As a result of the changing perspective of consumers towards genetic testing and rising expenditure. The increasing amount of disposable income allows consumers to spend more on direct-to-consumer genetic testing, such as ancestral and nutrigenomics tests and continuous projects are forecast to drive the market growth in the region.

Leading Competitors

The leading prominent companies profiled in the global direct-to-consumer genetic testing market are:

Easy DNA
Ancestry
Color Genomics
Full Genome Corporation
Helix OpCo LLC
Identigene
Karmagenes
FamilyTreeDNA
Mapmygenome
Pathway genomics
Genesis Healthcare
Other Prominent Players
Scope of the Report

The global direct-to-consumer genetic testing market segmentation focuses on Technology, Distribution Channel, Product Type, and Region.

Segmentation based on Technology

Single Nucleotide Polymorphism
Targeted Analysis
Whole Genome Sequencing
Segmentation based on Distribution Channel

Online Channel
over-the-counter (OTC) Channel
Segmentation based on Product Type

Ancestry
Health and Wellness
Entertainment
Segmentation based on Region

North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America